scholarly journals Beneficial effects of pomegranate peel extract treatment on anthropometry and body composition of overweight patients with diabetes mellitus type-2: A randomised clinical trial

2020 ◽  
Vol 51 (1) ◽  
pp. 21-27
Author(s):  
Milkica Grabež ◽  
Ranko Škrbić ◽  
Miloš Stojiljković ◽  
Vesna Rudić-Grujić ◽  
Katarina Šavikin ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Diabetes Mellitus Type 2 ◽  
Randomised Clinical Trial ◽  
Pomegranate Peel ◽  
Beneficial Effects ◽  
Patients With Diabetes ◽  
Pomegranate Peel Extract ◽  
Peel Extract

Relationship between obstructive sleep apnea syndrome and functional capacity in patients with diabetes mellitus type 2: an observational transversal study

2021 ◽  
Vol 67 (6) ◽  
pp. 878-881
Author(s):  
Moyrane Abreu da Fonseca ◽  
Alana Karina Silva Moreira ◽  
Railsa Bertilla dos Santos Lima ◽  
Marcela de Araújo Oliveira ◽  
Aldair Darlan Santos-de-Araújo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Diabetes Mellitus Type 2 ◽  
Sleep Apnea Syndrome ◽  
Obstructive Sleep ◽  
Patients With Diabetes ◽  
Apnea Syndrome ◽  
Transversal Study

scholarly journals Association between obesity and depression in patients with diabetes mellitus type 2; a study protocol

F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 7 ◽  
Author(s):  
Eduardo De la Cruz-Cano ◽  
Carlos Alfonso Tovilla-Zarate ◽  
Emilio Reyes-Ramos ◽  
Thelma Beatriz Gonzalez-Castro ◽  
Isela Juarez-Castro ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Diabetes Mellitus Type 2 ◽  
Cross Sectional Study ◽  
Diabetes Mellitus Type ◽  
Sectional Study ◽  
Cross Sectional ◽  
The World ◽  
Patients With Diabetes

Background: Diabetes mellitus and depression are highly prevalent conditions throughout the world and have significant impact on health outcomes. It has been estimated that diabetes mellitus type 2 affects about 246 million people in the world; nevertheless, incidence varies among countries. There is evidence that depression is associated with a poor metabolic control in patients with type 2 diabetes mellitus that present other health problems (such as hypertension and obesity). The aim of this study protocol is to determine if obesity increases the risk for depression in patient with diabetes type 2.Methods: The analysis will be reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).The studies suitable for inclusion will be assessed by the Newcastle-Ottawa Scale (NOS) to determine their methodological quality. To identify the studies of interest, we will search on PubMed and EBSCO databases. We will use the following keyword combinations: "Diabetes Mellitus type 2 AND obesity AND depression", "depression AND Diabetes Mellitus type 2", "Diabetes Mellitus type 2 AND body mass index cross sectional study", "depression AND obesity cross-sectional study". Causes for exclusion will be publications that studied patients diagnosed with diabetes mellitus type 1; articles that focused on the treatment and complications of diabetes mellitus type 2; publications that have studied other clinical or psychiatric conditions (for instance, seizure disorder or history of schizophrenia, bipolar disorder, psychotic symptoms or dementia).Conclusion: The results of this study will form the basis for a better understanding of the association between obesity and depression in patients with diabetes mellitus type 2, and will allow development of prediction tools and better interventions. It is evident that several modifiable and non-modifiable risk factors play an important role in the pathogenesis of diabetes among population. Currently, evidence for the deleterious effects of diabetes mellitus type 2 are based on cross-sectional or other observational designs. Therefore, this study will have important implications for future research and public health guidance.

Sign in / Sign up

Export Citation Format

Share Document